1-2 of 2
Josep M. Martí
Close
Sort by
Journal Articles

Validation of the European Leukemia Net (ELN) Genetic Classification of Acute Myeloid Leukemia: Inclusion of Monosomal Karyotype Improves Prognostic Discrimination

Montserrat Hoyos, Salut Brunet, Josep F. Nomdedeu, MD, Jordi Esteve, MD, PhD, Rafael F. Duarte, MD, PhD, Josep-Maria Ribera, MD, PhD, Mar Tormo, MD, PhD, Andreu Llorente, Ramon Guardia, M. Paz Queipo, Javier Bueno, Juan Besalduch, Pio Torres, Inmaculada Heras, Carmen Pedro, Josep M. Martí-Tutusaus, Antoni Garcia, Joan Bargay, Llorenç Font, Antonia Sampol, MD, PhD, Olga Salamero, MD, David Gallardo, MD, PhD, Lourdes Escoda, Marisa Calabuig, Montserrat Arnan, Marta Pratcorona, Jorge Sierra, MD
Journal: Blood
Blood (2010) 116 (21): 1712.
https://doi.org/10.1182/blood.V116.21.1712.1712
Published: 2010
Journal Articles

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA

Clinical Trials & Observations
Joan Bladé, Laura Rosiñol, Ana Sureda, Josep M. Ribera, Joaquín Díaz-Mediavilla, José García-Laraña, M. Victoria Mateos, Luis Palomera, Javier Fernández-Calvo, Josep M. Martí, Pilar Giraldo, Félix Carbonell, Manel Callís, Jesús Trujillo, Santiago Gardella, M. Jesús Moro, Abelardo Barez, Alfons Soler, Llorenç Font, Montserrat Fontanillas, Jesús San Miguel, for Programa para el Estudio de la Terapéutica en Hemopatía Maligna (PETHEMA)
Journal: Blood
Blood (2005) 106 (12): 3755–3759.
https://doi.org/10.1182/blood-2005-03-1301
Published: 2005